Top

Obesity Surgery

Published in:

01-01-2017 | Letter to Editor/LED Reply

EndoBarrier® in Grade I Obese Patients with Long-Standing Type 2 Diabetes: Role of Gastrointestinal Hormones in Glucose Metabolism

Author: Nuria Vilarrasa

Published in: Obesity Surgery | Issue 1/2017

Excerpt

In response to the letter to the Editor: …

Muñoz R, Dominguez A, Muñoz F, Muñoz C, Slako M, Turiel D, et al. Baseline glycated hemoglobin levels are associated with duodenal jejunal bypass liner-induced weight loss in obese patients. Surg Endosc. 2014;28(4):1056–62.CrossRefPubMed

De Jonge C, Rensen SS, Verdam FJ, et al. Endoscopic duodenal–jejunal bypass liner rapidly improves type 2 diabetes. Obes Surg. 2013;23(9):1354–60.CrossRefPubMed

De Jonge C, Rensen S, Verdam FJ, Vincent RP, Bloom SR, Buurman WA, et al. Impact of duodenal-jejunal exclusion on satiety hormones. Obes Surg. 2016;26:672–8.CrossRefPubMed

De Jonge C, Rensen SS, D’Agnolo HM, ND B, WA B, JW G. Six months of treatment with the endoscopic duodenal-jejunal bypass liner does not lead to decreased systemic inflammation in obese patients with type 2 siabetes. Obes Surg. 2014;24:337–41.CrossRefPubMed

Gregor MF, Hotamisligil GS. Inflammatory mechanisms in obesity. Annu Rev Immunol. 2011;29:415–45.CrossRefPubMed

Ouchi N, Parker JL, Lugus JJ, Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol. 2011;11(2):85–97.CrossRefPubMedPubMedCentral

Cottam DR, Mattar SG, Barinas-Mitchell E, Eid G, Kuller L, Kelley DE, Schauer PR. The chronic inflammatory hypothesis for the morbidity associated with morbid obesity: implications and effects of weight loss. Obes Surg. 2004;14(5):589–600.CrossRefPubMed

Vilarrasa N, Vendrell J, Sánchez-Santos R, Broch M, Megia A, Masdevall C, Gomez N, Soler J, Pujol J, Bettónica C, Aranda H, Gómez JM. Effect of weight loss induced by gastric bypass on proinflammatory interleukin-18, soluble tumour necrosis factor-alpha receptors, C-reactive protein and adiponectin in morbidly obese patients. Clin Endocrinol. 2007;67(5):679–86.CrossRef

Rohde U, Hedbäck N, Gluud LL, Vilsbøll T, Knop FK. Effect of the EndoBarrier Gastrointestinal Liner on obesity and type 2 diabetes: a systematic review and meta-analysis. Diabetes Obes Metab. 2016;18(3):300–5.CrossRefPubMed

Title: EndoBarrier® in Grade I Obese Patients with Long-Standing Type 2 Diabetes: Role of Gastrointestinal Hormones in Glucose Metabolism
Author: Nuria Vilarrasa
Publication date: 01-01-2017
Publisher: Springer US
Published in: Obesity Surgery / Issue 1/2017
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI: https://doi.org/10.1007/s11695-016-2405-8

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

EndoBarrier® in Grade I Obese Patients with Long-Standing Type 2 Diabetes: Role of Gastrointestinal Hormones in Glucose Metabolism

Excerpt

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2017

TSH Normalization in Bariatric Surgery Patients After the Switch from l-Thyroxine in Tablet to an Oral Liquid Formulation

Two-Year Outcomes of Vagal Nerve Blocking (vBloc) for the Treatment of Obesity in the ReCharge Trial

Pediatric Nonalcoholic Fatty Liver Disease: the Rise of a Lethal Disease Among Mexican American Hispanic Children

Roux-En-Y Gastric Bypass Vs. Sleeve Gastrectomy: Balancing the Risks of Surgery with the Benefits of Weight Loss

A New Concept in Bariatric Surgery. Single Anastomosis Gastro-Ileal (SAGI): Technical Details and Preliminary Results

Endobarrier® in Grade I Obese Patients with Long-Standing Type 2 Diabetes: Role of Gastrointestinal Hormones in Glucose Metabolism